Thursday, January 9, 2025

These 7 Stocks Turned $7k Into 7 Figures


In order to unsubscribe from this mailing list, please click here

This New “Green Day” Strategy Is Cool

"It's tough to make predictions, especially about the future."

Friday's Watchlist Topper: Tiny Float (Nasdaq: ZVSA) Is A Clinical Stage Biopharma On Radar

Friday's Watchlist Topper: Tiny Float (Nasdaq: ZVSA) Is A Clinical Stage Biopharma On Radar


January 9th

Greetings, Friend!


On my watchlist for Friday morning: ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA).


And for one reason above all others...


That's because (Nasdaq: ZVSA) has a very small float.


Tallying approximately 1.02Mn shares according to Yahoo Finance, its small float size has the potential to drive significant chart swings in short periods of time.


The emergence of a suitable potential catalyst could trigger a surge in volatility, unleashing rapid and unpredictable market movements.


ZyVersa Therapeutics, Inc. (ZVSA) is a clinical stage specialty biopharmaceutical company leveraging advanced proprietary technologies to develop first-in-class drugs for patients with inflammatory or kidney diseases with high unmet medical needs.


ZyVersa Therapeutics Pipeline

They are well positioned in the rapidly emerging inflammasome space with a highly differentiated monoclonal antibody, Inflammasome ASC Inhibitor IC 100, and in kidney disease with phase 2 Cholesterol Efflux MediatorTM VAR 200.


The lead indication for IC 100 is obesity with metabolic complications, and for VAR 200, focal segmental glomerulosclerosis (FSGS).


Each therapeutic area offers a “pipeline within a product,” with potential for numerous indications.


Grab Sources: ZVSA Presentation.

-----


ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA) just climbed to the top spot on my watchlist going into Friday.


I'll be in touch with updates when necessary. Talk again shortly.


All the best,

Dane James

Editor Market Pulse Today



(Remember: St-ock Prices Could Be Significantly Lower Now From The Original Dates I Provided.)


MarketPulseToday.com (“MarketPulseToday” or “MPT” ) is owned by Thousand Sun Media LLC, a single member limited liability company. Data is provided from third-party sources and MarketPulseToday is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile MPT brings to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized in-vest-ment advice, are not in-vest-ment advisors, and any profiles we mention are not suitable for all in-vest-ors.


Thousand Sun Media LLC has not been compensated for the January 9th and 10th, 2025's profile on (ZVSA:US).


Neither Thousand Sun Media LLC or its member own shares of (ZVSA:US).


Please see important disclosure information here: https://marketpulsetoday.com/disclosure/

🎯 Your Premium Stock Signals (Jan 9)

Open Email...Your Evening Stock Signals Report Inside…
Daily Stock Signals

Unsubscribe

Dear Reader,
I hope you are having a great Thursday! I am sending you the list of stock signals for the next trading day (to help you cut your research in finding trading and/or investing opportunities).

💡 Must Read: The Art of Discovering Little-Known Companies (ad)
The market is changing, and as 2024 winds down, one thing is clear: if speed isn't part of your strategy, you might miss out on hidden gems.
👉 Click here to get your free report now. (By clicking this link, you are subscribing to receive messages from Fierce Investor

Stock NameSignal DateSignal Name
XOMJan 9 Golden Crossover
JNJJan 9 Golden Crossover
CVXJan 9 Golden Crossover
LINJan 9 Golden Crossover
MSFTJan 9 Below 200-MA
ABBVJan 9 Below 200-MA
CARRJan 9 Below 200-MA
CPNGJan 9 Below 200-MA
METAJan 9 Double Top
PMJan 9 Double Top
FASTJan 9 Double Top
HOODJan 9 Double Top
UPSJan 9 Double Bottom
BPJan 9 Double Bottom
DEOJan 9 Double Bottom
EQNRJan 9 Double Bottom
Click Here to View Your Full Report

Don't let this chance slip away (ad)
The stock market is full of untapped gems, and the greatest potential often lies in discovering little-known companies before they break out. We're thrilled to offer you our Wealth Building Report, which will reveal a curated list of little-known companies with massive growth potential for 2025.
[Claim Your Free Report Now] (By clicking this link, you are subscribing to receive emails from Krypton Street Newsletter. Unsubscribing is easy.)

How to use signals in your trading/investing strategies:
Options Trading - if you are an Options trader, you can use the Ride-the-Wave strategy (to target multi-day price momentum following a company's trade signal) or the Price Reversal strategy (to target the reversal following signal generation). Please click on Ride-the-Wave Strategy to learn more about it.
Stock Trading - If you're a swing stock trader/investor or portfolio manager, you may want to consider entering or exiting your positiosn based on a the signal generation. Please click on Volatility Crush Strategy to learn more about it.

🌍 The future of AI "depends" on this firm's work (ad)
At least $32 billion in funding could flow into cutting-edge AI firms over the next three years. Which opens up an incredible opportunity for early investors. Get in before the coming wave of government spending could send this stock soaring.
👉 Click here for the ticker >>> (By clicking the link above, you agree to receive emails from Behind the Markets free newsletter and our partners. You may unsubscribe at any time.)

At Daily Stock Signals, we're really excited to help you trade more confidently. To that end, we're constantly developing new content to go alongside our platform insights, which will further our mission to help you become a better trader.
To your trading success,
Support Team
Daily Stock Signals
PS: Daily Stock Signals is evening newsletter, powered by StockEarnings proprietary technology.
Daily Stock Signals SMS is Here! 
Join SMS Text and never miss any stock trade alerts or special offers from Daily Stock Signals and our advertising partners ever again...
Click right here to join Daily Stock Signals SMS List

Daily Stock Signals is a subsidiary of StockEarnings, Inc (SE). SE is a research service not owned or managed by registered brokers and therefore this site does not make any investment recommendations. The information provided in this newsletter is not guaranteed as to the accuracy or completeness. Each user of SE chooses to do trades at their sole discretion and risk. SE is not responsible for gains/losses that may result in the trading of these securities.

This newsletter includes paid advertisements. The source of all third-party content in which SE receives some sort of compensation, is clearly and prominently identified herein as "ad" or "Sponsored". Although we have sent you these advertisements, SE does not specifically endorse any third-party product nor is it responsible for the content of the advertisement or the experience with the third-party advertiser. Furthermore, we make no guarantee or warranty about what is advertised.

All investments involve risk, losses may exceed the principal invested, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Please click here for SE Disclaimers.

StockEarnings Inc. 33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA | W: 877.6.STOCKS

Unsubscribe


Today's Bonus Content: Has Trump finally met his match?

(By clicking the link above, you'll be opted into Behind the Markets free newsletter. You may unsubscribe at any time.)

ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA) Just Claimed The Top Spot On My Watchlist (Low Float)

ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA) Just Claimed The Top Spot On My Watchlist (Low Float)


January 9th

Dear Reader,


For Friday's opening bell, consider getting ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA) on your radar.


Here's the main reason why...


ZVSA is a low float profile.


With roughly 1.02Mn shares, its minuscule float could create an environment of extreme volatility in moments.


And if the right potential catalyst comes along, it could act as the spark for volatility to run rampant.


ZyVersa Therapeutics, Inc. (ZVSA) is a clinical stage specialty biopharmaceutical company leveraging advanced proprietary technologies to develop first-in-class drugs for patients with inflammatory or kidney diseases with high unmet medical needs.


They are well positioned in the rapidly emerging inflammasome space with a highly differentiated monoclonal antibody, Inflammasome ASC Inhibitor IC 100, and in kidney disease with phase 2 Cholesterol Efflux MediatorTM VAR 200.


The lead indication for IC 100 is obesity with metabolic complications, and for VAR 200, focal segmental glomerulosclerosis (FSGS).


Each therapeutic area offers a “pipeline within a product,” with potential for numerous indications.


The total accessible market is over $100Bn.


Find key sources here: ZVSA Presentation.

-----


Coverage is officially initiated on ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA).


When updates are available, I'll have them out quickly. Talk soon.


Sincerely,

FierceAnalyst | Jaks Swift

Editorial Writer



(Always Remember The St-ock Prices Could Be Significantly Lower Now From The Dates I Provided.)


FierceInvestor (FierceInvestor . com) is owned by SWN Media LLC, a limited liability company. Data is provided from third-party sources and FierceInvestor ("FI") is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile I bring to your attention. We do not provide personalized fin-ancial advice, are not finan-cial advisors, and our opinions are not suitable for all in-vest-ors.


SWN Media LLC has not been compensated for the January 9th and 10th, 2025's profile on (ZVSA:US).


Neither SWN Media LLC or its member own shares of (ZVSA:US).


Please see important disclosure information here: https://www.fierceanalyst.net/disclosure/